Outcomes of cytologically indeterminate thyroid nodules managed with Genomic Sequencing Classifier.
Sara AhmadiYogish C KudvaAthanasios BikasPingping XiangWhitney S GoldnerAnery PatelElena G HughesXochitl R LongstaffMichael W YehMasha J LivhitsPublished in: The Journal of clinical endocrinology and metabolism (2024)
GSC is a key tool for managing patients with indeterminate cytology, including the higher-risk Bethesda IV category. GSC benign thyroid nodules can be observed similarly to thyroid nodules with benign cytology.